Cash & Henderson Drugs v. Johnson & Johnson, No. 12-4689 (2d Cir. 2015)
Annotate this CasePlaintiffs, a group of 28 retail pharmacies, filed suit against defendants, primarily pharmaceutical manufacturers, alleging claims for money damages and injunctive relief under subsections 2(a), 2(d), and 2(f) of the Robinson‐Patman Act, 15 U.S.C.13(a), 13(d), 13(f), and sections 4 and 16 of the Clayton Act, 15 U.S.C. 15, 26. Plaintiffs’ main contentions are that the lower prices offered by manufacturers violate the Robinson‐Patman Act by harming their ability to compete, and that favored purchasers violated the Act by using their drug formularies to extract the lower prices. Plaintiffs sought to prove that discounts caused them to lose customers to the favored purchasers, and that as a consequence they suffered injury under the antitrust laws. The district court concluded that plaintiffs could prove neither type of injury and granted defendants summary judgment. The court concluded that, given that an extended discovery process resulted in almost no evidence of diverted sales or other indicia of potential competitive injury, summary judgment was appropriate on the section 2(a) claims; plaintiffs failed to raise a genuine issue of material fact as to competitive injury and antitrust injury; injunctive relief is inappropriate where plaintiffs have offered no argument that future conditions will change in such a way as to make the injuries they claim to have suffered more pronounced than currently alleged; and since plaintiffs failed to show competitive or antitrust injury with regard to their section 2(a) claim, summary judgment is appropriate with respect to their claims under sections 2(d) and 2(f) as well. Accordingly, the court affirmed the judgment.
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.